These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8122637)

  • 1. Aspects of the theoretical basis and clinical relevance of low acid states.
    Modlin IM; Goldenring JR; Lawton GP; Hunt R
    Am J Gastroenterol; 1994 Mar; 89(3):308-18. PubMed ID: 8122637
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux disease: current treatment approaches.
    Biddle W
    Director; 2003; 11(4):155-9. PubMed ID: 14608699
    [No Abstract]   [Full Text] [Related]  

  • 4. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intestinal infections due to inhibition of gastric acid secretion in reflux disease].
    Otten MH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2511-4. PubMed ID: 10627752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors in the management of GORD and PUD.
    Kenny E
    Ir Med J; 1993; 86(4):114. PubMed ID: 8395486
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of peptic ulcers and GERD.
    Treat Guidel Med Lett; 2008 Aug; 6(72):55-60. PubMed ID: 18654113
    [No Abstract]   [Full Text] [Related]  

  • 8. Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression.
    Malfertheiner P; Fass R; Quigley EM; Modlin IM; Malagelada JR; Moss SF; Holtmann G; Goh KL; Katelaris P; Stanghellini V; Talley NJ; Tytgat GN; Wright NA
    Aliment Pharmacol Ther; 2006 Mar; 23(6):683-90. PubMed ID: 16556170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid rebound: fact or fiction.
    Holtermüller KH
    Hepatogastroenterology; 1982 Aug; 29(4):135-7. PubMed ID: 7129334
    [No Abstract]   [Full Text] [Related]  

  • 11. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.
    Andersson K; Carlsson E
    Pharmacol Ther; 2005 Dec; 108(3):294-307. PubMed ID: 16000224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical treating of antacids].
    Lux G; Lux E
    Fortschr Med; 1973 May; 91(14):638-40. PubMed ID: 4540765
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlling acid secretion: individual variation in response.
    Walt RP
    Br J Clin Pract Suppl; 1994; 75():9-12; discussion 13. PubMed ID: 8060804
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study].
    Hurenkamp GJ; Grundmeijer HG; van der Ende A; Tytgat GN; Assendelft WJ; van der Hulst RW
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2390-6. PubMed ID: 15615275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term acid control and proton pump inhibitors: interactions and safety issues in perspective.
    Freston JW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):51S-55S; discussion 55S-57S. PubMed ID: 9127627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects of Kvamatel (famotidine) administration].
    Golochevskaia VS
    Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapeutic arsenal in the medical treatment of gastroduodenal ulcer disease].
    Vallot T; Bonfils S
    Rev Prat; 1985 Feb; 35(9):449-57. PubMed ID: 3983550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.